dronabinol has been researched along with Psychoses in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.63) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (13.95) | 29.6817 |
| 2010's | 24 (55.81) | 24.3611 |
| 2020's | 8 (18.60) | 2.80 |
| Authors | Studies |
|---|---|
| Freeman, TP; Lorenzetti, V | 1 |
| Dotson, S; Evins, AE; Johnson-Arbor, K; Schuster, RM; Tervo-Clemmens, B | 1 |
| Lange, N | 1 |
| Boks, MP; Conrod, P; de Witte, LD; Eijk, KV; Elkrief, L; Gastel, WV; He, Y; Hol, EM; Huguet, G; Kahn, RS; Paus, T; Schubart, CD; Vinkers, CH | 1 |
| Bhattacharyya, S; Diederen, K; Gunasekera, B | 1 |
| Chakravarty, MM; Cupo, L; Guma, E; Plitman, E | 1 |
| Dahlén, A; Guo, S; Melgoza, A; Wagle, M; Zarei, M | 1 |
| Barhum, Y; Barzilay, R; Ben-Zur, T; Gazit, N; Gil-Ad, I; Hornfeld, SH; Kamiya, A; Niwa, M; Offen, D; Sawa, A; Segal-Gavish, H; Slutsky, I; Taler, M; Weizman, A | 1 |
| Hull, M; Medlin, H; Nussbaum, A; Rylander, M; Winston, HR | 1 |
| de Haan, L; Dekker, M; Schipper, R; van den Brink, W | 1 |
| Bhattacharyya, S; Colizzi, M; Lythgoe, D; McGuire, P; Van Oudenhove, L; Weltens, N; Williams, S | 1 |
| D'Souza, DC; De Aquino, JP; Gupta, S; Ranganathan, M | 1 |
| Herman, MS; Rosenzweig, I; Vukadinovic, Z | 1 |
| Ceccarini, J; Henquet, C; Kuepper, R; Lataster, J; Marcelis, M; van Gerven, JM; van Kroonenburgh, M; Van Laere, K; van Os, J | 1 |
| Antonelli, T; Beggiato, S; Ferraro, L; Parolaro, D; Prini, P; Rubino, T; Steardo, L; Zamberletti, E | 1 |
| Bois, F; Cahill, J; Carbuto, M; Cortes-Briones, J; D'Souza, DC; Gunduz-Bruce, H; Pittman, B; Radhakrishnan, R; Ranganathan, M; Schnakenberg, A; Sewell, RA; Skosnik, PD | 1 |
| Cahill, JD; Cortes-Briones, JA; D'Souza, DC; Ford, JM; Mathalon, DH; Ranganathan, M; Roach, BJ; Sewell, RA; Skosnik, PD; Williams, A | 1 |
| Behlke, I; Bhattacharyya, S; Kambeitz, J; Murray, R; Schoeler, T | 1 |
| Ball, SA; D'Souza, DC; Radhakrishnan, R; Wilkinson, ST; Yarnell, S | 1 |
| Cortes-Briones, JA; Hajós, M; Skosnik, PD | 1 |
| Bäcker, C; Frey, R; Kasper, S; Kaufmann, RM; Kraft, B; Kress, HG; Weiszenbichler, S; Winkler, D | 1 |
| Henquet, C; Kenis, G; Kuepper, R; Morrison, PD; Murray, RM; van Os, J | 1 |
| Behan, A; Cannon, M; Cotter, DR; Coughlan, C; Desbonnet, L; Gogos, JA; Hryniewiecka, M; Karayiorgou, M; O'Tuathaigh, CM; Tighe, O; Waddington, JL | 1 |
| Barkus, E; Brenneisen, R; Dickson, JC; Ell, PJ; Holt, DW; Kapur, S; Morrison, PD; Murray, RM; Pilowsky, LS; Powell, J; Vuletic, D | 1 |
| Karajgi, B; Schwarcz, G | 1 |
| Boks, MP; Goetgebuer, RL; Kahn, RS; Schubart, CD; Sommer, IE; van Gastel, WA | 1 |
| Dekker, N; Koeter, MW; Meijer, CJ; Meijer, JH; Quee, PJ; van Beveren, NJ | 1 |
| Barrowclough, C; Beardmore, R; Eisner, E; Emsley, R; Wykes, T | 1 |
| Arendt, M; Fohlmann, A; Hjorthøj, CR; Larsen, AM; Nordentoft, M | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Brammer, M; Crippa, JA; Fusar-Poli, P; Giampietro, V; Kambeitz, J; Martin-Santos, R; McGuire, PK; O'Carroll, C; Rubia, K; Seal, ML; Zuardi, AW | 1 |
| de Kam, M; Hijman, R; Jacobs, G; Klaassen, E; Kleinloog, D; Liem-Moolenaar, M; van Gerven, J | 1 |
| Abi-Saab, WM; Braley, G; Cooper, TB; D'Souza, DC; Doersch, A; Forselius-Bielen, K; Gueorguieva, R; Krystal, JH; Madonick, S | 1 |
| Double, DB | 1 |
| Drukker, M; Fananás, L; Henquet, C; Krabbendam, L; Papiol, S; Ramaekers, JG; Rosa, A; van Os, J | 1 |
| Grech, A | 1 |
| Shufman, E; Witztum, E | 1 |
| Fritzsche, M | 1 |
| Bickel, P; Dittrich, A; Zimmer, D | 1 |
| Jiang, ZN | 1 |
| Nahas, GG | 1 |
| de Voss, R; Lemmingson, O; Lüllmann, H; Prooter, H | 1 |
| Ablon, SL; Goodwin, FK | 1 |
9 review(s) available for dronabinol and Psychoses
| Article | Year |
|---|---|
Cannabinoids, reward processing, and psychosis.
Topics: Antipsychotic Agents; Cannabidiol; Cannabinoids; Dopamine; Dronabinol; Humans; Psychotic Disorders; Reward | 2022 |
A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neuroimaging; Psychotic Disorders | 2021 |
Cannabis, psychosis and the thalamus: a theoretical review.
Topics: Animals; Calcium Channels, T-Type; Cannabinoids; Cannabis; Cerebral Cortex; Dronabinol; Electroencephalography; Hallucinogens; Humans; Neural Pathways; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thalamus | 2013 |
The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis.
Topics: Adult; Cannabinoid Receptor Agonists; Dronabinol; Humans; Memory; Memory Disorders; Psychotic Disorders | 2016 |
Marijuana Legalization: Impact on Physicians and Public Health.
Topics: Automobile Driving; Cannabis; Cognition Disorders; Dronabinol; Humans; Illicit Drugs; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Opioid-Related Disorders; Prevalence; Psychotic Disorders; Public Health; United States | 2016 |
It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis.
Topics: Attention; Brain; Cannabinoid Receptor Agonists; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Marijuana Smoking; Memory, Short-Term; Psychomotor Performance; Psychotic Disorders; Schizophrenia | 2016 |
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines.
Topics: Animals; Cannabis; Cerebral Cortex; Dopamine; Dronabinol; Humans; Marijuana Abuse; Neural Pathways; Psychotic Disorders | 2010 |
[Present status and trends in drug dependence].
Topics: Dronabinol; Humans; Morphine Dependence; Phencyclidine Abuse; Phenmetrazine; Psychotic Disorders; Substance-Related Disorders | 1985 |
Cannabis: toxicological properties and epidemiological aspects.
Topics: Adolescent; Alcohol Drinking; Animals; Biological Availability; Brain; Cannabinoids; Cannabis; Child; Cognition; Dronabinol; Drug Interactions; Female; Fetus; France; Humans; Immune System; Infant, Newborn; Lung; Male; Marijuana Abuse; Pregnancy; Psychotic Disorders; Reproduction; Scotland; Substance-Related Disorders; United States | 1986 |
12 trial(s) available for dronabinol and Psychoses
| Article | Year |
|---|---|
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.
Topics: Corpus Striatum; Double-Blind Method; Dronabinol; Glutamic Acid; Hallucinogens; Humans; Male; Psychotic Disorders | 2020 |
GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.
Topics: Adolescent; Adult; Brain Mapping; Dissociative Disorders; Double-Blind Method; Dronabinol; Electroencephalography; Event-Related Potentials, P300; Flumazenil; gamma-Aminobutyric Acid; Humans; Male; Pain Measurement; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Young Adult | 2015 |
The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.
Topics: Adolescent; Adult; Cerebral Cortex; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Electroencephalography; Female; Hallucinogens; Healthy Volunteers; Humans; Male; Noise; Psychiatric Status Rating Scales; Psychotic Disorders; Young Adult | 2015 |
Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers.
Topics: Administration, Oral; Adult; Analysis of Variance; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Pain Measurement; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Performance; Psychotic Disorders; Self Concept; Time Factors; Young Adult | 2010 |
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study.
Topics: Adult; Corpus Striatum; Dopamine; Double-Blind Method; Dronabinol; Hallucinogens; Humans; Infusions, Intravenous; Male; Psychotic Disorders; Tomography, Emission-Computed, Single-Photon | 2011 |
Does change in cannabis use in established psychosis affect clinical outcome?
Topics: Adult; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Hospitalization; Humans; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Prospective Studies; Psychotic Disorders; Substance-Related Disorders | 2013 |
Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clin
Topics: Biomarkers; Chromatography, High Pressure Liquid; Dronabinol; Female; Humans; Male; Marijuana Abuse; Psychotic Disorders; ROC Curve; Self Report; Substance Abuse Detection | 2012 |
Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?
Topics: Absorption; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Interactions; Drug Users; Hallucinogens; Histamine H1 Antagonists; Humans; Male; Metabolic Clearance Rate; Middle Aged; Netherlands; Neurotoxicity Syndromes; Olanzapine; Psychotic Disorders; Young Adult | 2012 |
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
Topics: Adult; Akathisia, Drug-Induced; Arousal; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Endocrine System; Female; Humans; Injections, Intravenous; Male; Mental Recall; Middle Aged; Motor Activity; Neuropsychological Tests; Perception; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Verbal Learning | 2005 |
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; Brain; Catechol O-Methyltransferase; Cognition Disorders; Cross-Over Studies; DNA Mutational Analysis; Dopamine; Double-Blind Method; Dronabinol; Environmental Exposure; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Middle Aged; Placebos; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders | 2006 |
[Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)].
Topics: Administration, Oral; Adult; Cannabis; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Methods; Personality Assessment; Placebos; Psychological Tests; Psychotic Disorders | 1975 |
High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients.
Topics: Adult; Anger; Antidepressive Agents; Anxiety; Cannabis; Clinical Trials as Topic; Depression; Dronabinol; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Psychotic Disorders | 1974 |
22 other study(ies) available for dronabinol and Psychoses
| Article | Year |
|---|---|
A standard THC unit for reporting of health research on cannabis and cannabinoids.
Topics: Cannabinoids; Cannabis; Chronic Pain; Dronabinol; Drug Compounding; Drug Dosage Calculations; Health Services Research; Humans; Neuroanatomy; Psychotic Disorders; Research Report; Substance-Related Disorders | 2021 |
Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution.
Topics: Behavior, Addictive; Cannabis; Dronabinol; Humans; Psychotic Disorders | 2022 |
Editorial: Brain Mediators of the Cannabis-Prodromal Psychosis Connection.
Topics: Brain; Cannabis; Dronabinol; Humans; Parahippocampal Gyrus; Psychotic Disorders | 2020 |
Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Psychotic Disorders; Receptors, Purinergic P2X; Receptors, Purinergic P2X7 | 2020 |
THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dronabinol; N-Methylaspartate; Piperidines; Psychotic Disorders; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Stereotyped Behavior; Zebrafish | 2021 |
BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction.
Topics: Adolescent; Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Cannabis; Cognition; Cognition Disorders; Disease Models, Animal; Dronabinol; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Psychotic Disorders | 2017 |
The association of cannabis use on inpatient psychiatric hospital outcomes.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Dronabinol; Female; Hospitals, Psychiatric; Humans; Inpatients; Length of Stay; Male; Marijuana Use; Middle Aged; Patient Readmission; Psychotic Disorders; Treatment Outcome; Young Adult | 2018 |
Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series.
Topics: Adult; Antipsychotic Agents; Cannabidiol; Cannabis; Comorbidity; Dronabinol; Female; Humans; Inpatients; Male; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Middle Aged; Psychotic Disorders; Young Adult | 2018 |
Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Dronabinol; Female; Haloperidol; Humans; Male; Perception; Psychotic Disorders; Psychotropic Drugs; Young Adult | 2019 |
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.
Topics: Administration, Inhalation; Adult; Benzamides; Caudate Nucleus; Dopamine; Dronabinol; Female; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Risk Factors; Substance-Related Disorders | 2013 |
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
Topics: Age Factors; Animals; Animals, Newborn; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Motor Activity; Phencyclidine; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Stereotyped Behavior; Synaptic Transmission | 2014 |
Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.
Topics: Age Factors; Animals; Catechol O-Methyltransferase; Dronabinol; Exploratory Behavior; Female; Male; Mice; Mice, Knockout; Mutation; Phenotype; Psychotic Disorders; Random Allocation | 2010 |
Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs.
Topics: Adolescent; Adult; Belgium; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Dronabinol; Female; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Middle Aged; Netherlands; Phenotype; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Risk Assessment; Schizotypal Personality Disorder; Siblings; Young Adult | 2011 |
Improvement in refractory psychosis with dronabinol: four case reports.
Topics: Adult; Antipsychotic Agents; Dronabinol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia, Paranoid; Treatment Outcome; Young Adult | 2010 |
Cannabis with high cannabidiol content is associated with fewer psychotic experiences.
Topics: Adolescent; Age of Onset; Analysis of Variance; Cannabinoids; Cross-Sectional Studies; Dronabinol; Female; Humans; Internet; Male; Marijuana Abuse; Netherlands; Psychotic Disorders; Retrospective Studies; Self Report; Time Factors; Young Adult | 2011 |
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Topics: Adolescent; Adult; Cognition; Cognition Disorders; Cross-Sectional Studies; Dronabinol; Female; Genetic Predisposition to Disease; Humans; Interview, Psychological; Male; Marijuana Abuse; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Siblings; Young Adult | 2012 |
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.
Topics: Adult; Attention; Cannabidiol; Corpus Striatum; Dronabinol; Hallucinogens; Humans; Male; Prefrontal Cortex; Psychotic Disorders; Reaction Time; Space Perception; Young Adult | 2012 |
Cannabis and psychosis: let's start from the null hypothesis.
Topics: Cannabis; Dopamine; Dronabinol; Humans; Marijuana Abuse; Psychotic Disorders; Receptors, Cannabinoid; Synaptic Transmission | 2006 |
Should we advise patients with serious mental illness to stop using cannabis?
Topics: Attitude of Health Personnel; Attitude to Health; Comorbidity; Counseling; Diagnosis, Dual (Psychiatry); Dronabinol; Humans; Marijuana Abuse; Mental Disorders; Psychiatry; Psychotic Disorders; Schizophrenia | 2008 |
[Cannabis--a drug with dangerous implications for mental health].
Topics: Cannabis; Dronabinol; Humans; Marijuana Abuse; Mental Disorders; Mental Health; Psychotic Disorders; Psychotropic Drugs | 2000 |
Impaired information processing triggers altered states of consciousness.
Topics: Cannabis; Consciousness Disorders; Dronabinol; Entropy; Hallucinations; Humans; Information Theory; Mental Processes; Models, Psychological; Phenotype; Psychotic Disorders; Quantum Theory; Schizophrenic Psychology; Self Concept; Space Perception; Time Perception; Volition | 2002 |
[An animal test model for evaluating drugs with anti-mass-psychotic activity].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dronabinol; Ethanol; Female; Housing, Animal; Humans; Male; Mass Behavior; Models, Psychological; Psychotic Disorders; Psychotropic Drugs; Rodentia | 1974 |